Public Opening Position Disclosure by a Party to an Offer

Public Opening Position Disclosure by a Party to an Offer. Rules 8.1 and 8.2 of the Takeover Code. Download the full document here.

Back to Listing Previous Next

EKF Diagnostics

EKF Diagnostics Holdings plc is a manufacturer and distrbutor of IVD products. It has three core divisions: Point of Care including hemoglobin and HbA1c analyzers; Central Laboratory including the manufacture of enzymes and clinical chemistry; and Molecular Diagnostics which incorporates a unique DNA enrichment technology, PointMan, and a portfolio of molecular testing services.

News & events

New data using EKF PointMan™

EKF Diagnostics announces the latest results from its collaboration with the Institute of Life Sciences at the University of Swansea.

Contract win and regulatory approval

EKF Diagnostics announces that it has signed a new distribution contract in China and that one of its OEM partners has received further regulatory approval across several target territories.

Stanbio Life Sciences re-branded

Stanbio Life Sciences re-branded as EKF Life Sciences.

EKF collaborator to deliver Kelly West Lecture at ADA

Dr. Andrzej Krolewski recognized for significant contribution to diabetes epidemiology .

EKF Molecular Diagnostics and GILUPI announce CTC DNA enrichment success

EKF Molecular Diagnostics and GILUPI announces results from collaborative work using GILUPI CellCollectorTM and PointManTM DNA enrichment technology.